Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

The cash price for popular weight-loss medications Wegovy and and the medication authorized for people with type 2 diabetes ...

Democrats in the House have introduced a new bill that aims to further expand Medicare's ability to negotiate drug prices. | Democrats in the House have introduced a new bill that aims to further ...

Bill seeks to expand Medicare drug price negotiation program to 50 medications and extend authority to private ...

Panelists discuss how the Inflation Reduction Act (IRA) introduces landmark changes to drug pricing through its negotiation ...

Senate Democrats are demanding that President Trump release the list of the most recent Medicare-negotiated drug prices.

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness ...

The Danish company is trying to regain market share from Eli Lilly — which makes Mounjaro and Zepbound — by making its weight ...

Conservative state Rep. Samantha Poetter Parshall says President Donald Trump’s Most Favored Nation model is the wrong ...

The White House announced reduced pricing for the popular weight-loss drugs made by Eli Lilly and Novo Nordisk.

President Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

Pharmaceutical giant Merck announced the cancellation of a planned $1.3 billion research center in London and the termination ...